Reduced Chimeric Antigen Receptor T Cell Expansion Postinfusion Is Associated with Poor Survival in Patients with Large B Cell Lymphoma after Two or More Therapies.
Abadir E, Wayte R, Li W, Gupta S, Yang S, Reaiche E, Debosz K, Anderson E, Favaloro J, Aklilu E, Brown C, Bryant C, Dunkley S, McCulloch D, Larsen S, Rasko JEJ, Vanguru V, Ho PJ.
Abadir E, et al. Among authors: mcculloch d.
Transplant Cell Ther. 2025 Jan 6:S2666-6367(25)00002-8. doi: 10.1016/j.jtct.2025.01.001. Online ahead of print.
Transplant Cell Ther. 2025.
PMID: 39778811